Management of Multiple Drug-Resistant Infections (Infectious Disease (Totowa, N.J.).)

個数:

Management of Multiple Drug-Resistant Infections (Infectious Disease (Totowa, N.J.).)

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合、分割発送となる場合がございます。
    3. 美品のご指定は承りかねます。
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 403 p.
  • 言語 ENG
  • 商品コード 9781588292308
  • DDC分類 616.9041

基本説明

The authors focus on the major hospital and community-acquired pathogens, including S. aureus, S. pneumoniae, Enterococcus, Acinetobacter, and M. tuberculosis, and more.

Full Description

A comprehensive and cutting-edge review of how practicing physicians can best treat multiple drug resistance in bacterial, viral, protozoal, and helminthic infections. The authors focus on the major hospital and community-acquired pathogens, including S. aureus, S. pneumoniae, Enterococcus, Acinetobacter, and M. tuberculosis, and on the management of such common problems as multiple drug-resistant urinary tract infections and gonorrhea. Among the resistant tropical organisms covered are Salmonella typhi, malaria, and Burkholderia pseudomalei. Resistance to such important antiviral classes as antiretrovirals and anticytomegalovirals is also discussed, as are those measures necessary to prevent the spread of infections patients.

Contents

Part I: Gram-Positive Bacteria

Management of Community-Acquired Pneumonia Caused by Drug-Resistant Streptococcus pneumoniae
Eric L. Nuermberger and William R. Bishai

Management of Meningitis Caused by Resistant Streptococcus pneumoniae
P. Fernández Viladrich

Emerging Resistance to Vancomycin, Rifampin, and Fluoroquinolones in Streptococcus pneumoniae
Joseph M. Blondeau

Management of Glycopeptide-Resistant Staphylococcus aureus Infections
A. Peter R. Wilson

Infections Caused by Glycopeptide-Resistant Gram-Positive Bacteria Excluding Staphylococci
Armine Sefton

Isolation Policies and the Hospital Management of Methicillin-Resistant Staphylococcus aureus: A Case of Evidence-Free Medicine?
Sheldon P. Stone

Part II: Gram-Negative Pathogens

The Management of Resistant Acinetobacter Infections in the Intensive Therapy Unit
Nicola Baker and Peter Hawkey

Drug-Resistant Helicobacter pylori
Peter J. Jenks

The Management of Antibiotic-Resistant Neisseria gonorrhoeae
Catherine A. Ison and Jonathan Ross

Management of Urinary Tract Infections Caused by Multiresistant Organisms
Jeremy M. T. Hamilton-Miller

Management of Multiple Drug-Resistant Salmonella Infections
Christopher M. Parry

Management of Melioidosis
Andrew J. H. Simpson

Part III: Mycobacteria

The Molecular Epidemiology of MDR-TB
Paul D. van Helden, Robin M. Warren, Pieter Uys, Gian D. van der Spuy, and Thomas C. Victor

The Management of Multiple Drug-Resistant Tuberculosis
Sanjay Bhagani and Marc Lipman

Management of Infection With Nontuberculosis Mycobacteria
Stephen H. Gillespie

Part IV: Fungal and Parasitic Infections

Management of Resistant Candida Infections
Sanya Clements and Christopher C. Kibbler

Management ofInfection With Naturally Amphotericin B-Resistant Fungi
Thean Yen Tan and Rosemary A. Barnes

Management of Multiple Drug-Resistant Malaria
Elizabeth Ashley and François Nosten

Schistosome Drug Resistance: Praziquantel
Michael J. Doenhoff and Katherine Wheatcroft-Francklow

Part V. Viral Infections

Management of HIV Drug-Resistant Infections
Deenan Pillay

Multidrug Resistance in Human Cytomegalovirus
Vincent C. Emery, Mohammad Raza Naqvee, and Anuradha Chawla

Index